ResearcherShandong UniversityNo recent work listed

Weibo Niu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8395-3442; OpenAlex author ID A5087333092. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2016: 1 paper

Papers 1

Integrin β6 acts as an unfavorable prognostic indicator and promotes cellular malignant behaviors via ERK-ETS1 pathway in pancreatic ductal adenocarcinoma (PDA… Last author DOI 10.1007/s13277-015-4353-7 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Huijie Gao · 1 shared paper, 2016 · strength 0.06
- Paper Integrin β6 acts as an unfavorable prognostic indicator and promotes cellular malignant behaviors via ERK-ETS1 pathway … DOI 10.1007/s13277-015-4353-7 ↗
Zequn Li · 1 shared paper, 2016 · strength 0.06
- Paper Integrin β6 acts as an unfavorable prognostic indicator and promotes cellular malignant behaviors via ERK-ETS1 pathway … DOI 10.1007/s13277-015-4353-7 ↗
Jun Niu · 1 shared paper, 2016 · strength 0.06
- Paper Integrin β6 acts as an unfavorable prognostic indicator and promotes cellular malignant behaviors via ERK-ETS1 pathway … DOI 10.1007/s13277-015-4353-7 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.